Belvedere Trading »

Champions Oncology shares owned by Belvedere Trading

Quarter-by-quarter ownership of Champions Oncology (CSBR) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Champions Oncology

Tip: Access up to 7 years of quarterly data

All positions including Champions Oncology held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Champions Oncology by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-06-30 $475k 74k 6.38

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Strategy Cl A New (MSTR)
Apple (AAPL)
Broadcom (AVGO)
Spdr Gold Tr Gold Shs Call Option (GLD)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Amazon (AMZN)
Advanced Micro Devices (AMD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Palantir Technologies Cl A (PLTR)

View all positions for Belvedere Trading

Top funds holding Champions Oncology

Battery Management Corp.
NEA Management Company
Vanguard Group
Tocqueville Asset Management
Renaissance Technologies
BlackRock
Geode Capital Management
Northern Trust
Acadian Asset Management
HighTower Advisors
Bank of New York Mellon
State Street Corporation
Dimensional Fund Advisors
Susquehanna International
Citadel Advisors

View all funds holding Champions Oncology